Monitoring of public healthcare benefit Sample Clauses

Monitoring of public healthcare benefit. In order to assist Wellcome in monitoring the public healthcare benefit derived from Wellcome funding, until the seventh (7th) anniversary of the date of first commercial sale of a Product in the Field anywhere in the world, regardless of whether Wellcome has converted the Loan or been repaid, the Company shall provide annually to Wellcome at the end of its financial year (or where the Company is exploiting the Project IPRs and/or Products in the Field via third parties, procure that such third parties provide annually to Wellcome) a summary, together with supporting data, of the efforts being taken to provide equitable access to the Product in the Field. This summary shall include the number of Products in the Field (including doses if applicable) sold, supplied or made available for distribution globally and in each country.
View SourceView Similar (2)
Monitoring of public healthcare benefit. In order to assist Wellcome in monitoring the public healthcare benefit derived from Wellcome funding, for the duration of exploitation of [Products] [in the Field] and regardless of whether Wellcome has converted the Loan or been repaid, the Company shall report annually to Wellcome at the end of its financial year (or where the Company is exploiting the Project IPRs and/or [Products] [in the Field] via third parties, procure that such third parties report annually to Wellcome) [the number of [doses of] [Products] [in the Field] sold, supplied or made available for distribution globally and in each country [where infections in the Field are endemic] [insert suitable metrics for measurement of outcomes and outputs of the funded Project to enable Wellcome to measure and track results]].16 Wellcome exploitation rights. If: the Company and/or any third party materially breaches the Company Diligence Obligations; and/or any Project IPRs or [Products] [in the Field] remain unexploited or not further developed by the Company and/or their licensees in any country [where infections in the Field are endemic] within [five (5) years] following completion of the Project; Wellcome shall have the option in its sole discretion by giving written notice to the Company to take responsibility on behalf of the Company for the development and exploitation of such Project IPRs [and Products] [in respect of any disease indication] [in the Field] [in the relevant countries] [in any country], which includes discretion to make any and all decisions (in consultation with the Company) regarding the negotiation, acceptance and conclusion of terms for any agreement regarding the development and exploitation of the Project IPRs [and Products] [in respect of that disease indication] [in the Field] (including development and exploitation by way of licence, sale, assignment, materials transfer or other transfer of rights), as well as any transaction which involves placing such unexploited Project IPRs into a separate corporate vehicle) [in that country] [in relevant countries]. If Wellcome exercises its right to exploit on behalf of the Company under Clause 14.4: within [three (3) months] of receipt of Wellcome’s written notice exercising its right to exploit, the Company shall: license or assign (in good faith and on a sublicensable basis and on the financial terms set out at Clause 14.9) the Project IPRs [and Products] [in respect of any disease indication] [in the Field] [in the relevan...
View Source

Related to Monitoring of public healthcare benefit

  • COVERED HEALTHCARE SERVICES This section describes covered healthcare services. This plan covers services only if they meet all of the following requirements: • Listed as a covered healthcare service in this section. The fact that a provider has prescribed or recommended a service, or that it is the only available treatment for an illness or injury does not mean it is a covered healthcare service under this plan. • Medically necessary, consistent with our medical policies and related guidelines at the time the services are provided. • Not listed in Exclusions Section. • Received while a member is enrolled in the plan. • Consistent with applicable state or federal law. We review medical necessity in accordance with our medical policies and related guidelines. Our medical policies can be found on our website. Our medical policies are written to help administer benefits for the purpose of claims payment. They are made available to you for informational purposes and are subject to change. Medical policies are not meant to be used as a guide for your medical treatment. Your medical treatment remains a decision made by you with your physician. If you have questions about our medical policies, please call Customer Service. When a new service or drug becomes available, when possible, we will review it within six (6) months of one of the events described below to determine whether the new service or drug will be covered: • the assignment of an American Medical Association (AMA) Current Procedural Terminology (CPT) code in the annual CPT publication; • final Food and Drug Administration (FDA) approval; • the assignment of processing codes other than CPT codes or approval by governing or regulatory bodies other than the FDA; • submission to us of a claim meeting the criteria above; and • generally, the first date an FDA approved prescription drug is available in pharmacies (for prescription drug coverage only). During the review period, new services and drugs are not covered. For all covered healthcare services, please see the Summary of Medical Benefits and the Summary of Pharmacy Benefits to determine the amount that you pay and any benefit limits.

  • NMHS Governance, Safety and Quality Requirements 2.1 Participates in the maintenance of a safe work environment. 2.2 Participates in an annual performance development review. 2.3 Supports the delivery of safe patient care and the consumers’ experience including participation in continuous quality improvement activities in accordance with the requirements of the National Safety and Quality Health Service Standards and other recognised health standards. 2.4 Completes mandatory training (including safety and quality training) as relevant to role. 2.5 Performs duties in accordance with Government, WA Health, North Metropolitan Health Service and Departmental / Program specific policies and procedures. 2.6 Abides by the WA Health Code of Conduct, Occupational Safety and Health legislation, the Disability Services Act and the Equal Opportunity Act.

  • Human and Financial Resources to Implement Safeguards Requirements The Borrower shall make available necessary budgetary and human resources to fully implement the EMP and the RP.

  • Please see the current Washtenaw Community College catalog for up-to-date program requirements Conditions & Requirements

  • Extended Health Care Benefits The City will provide for all employees by contract through an insurer selected by the City an Extended Health Care Plan which will provide extended health care benefits. The City shall pay one hundred per cent (100%) of the premiums, which will include any premiums payable under The Health Insurance Act, R.S.O. 1990, as amended.